---
title: "HighLife to initiate US pivotal study of transseptal mitral valve replacement system"
date: "2024-06-03T11:13:14.000Z"
publishedDate: "3 juin 2024"
summary: "HighLife SAS has announced that the US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to initiate a US pivotal study evaluating its transseptal mitral valve replacement (TSMVR) technology. The pivotal study is a single-arm, multicentre, prospective study assessing the safety and effectiveness of the HighLife TSMVR system in patients with [&#8230;] The post HighLife to initiate US pivotal study of transseptal mitral valve replacement system appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/highlife-us-pivotal-study/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-06-03-highlife-to-initiate-us-pivotal-study-of-transseptal-mitral-valve-replacement-system"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/09/HighLife_Logo_RVB.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/highlife-us-pivotal-study/"
---

![HighLife to initiate US pivotal study of transseptal mitral valve replacement system](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/09/HighLife_Logo_RVB.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/highlife-us-pivotal-study/*

## L’essentiel

HighLife SAS has announced that the US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to initiate a US pivotal study evaluating its transseptal mitral valve replacement (TSMVR) technology. The pivotal study is a single-arm, multicentre, prospective study assessing the safety and effectiveness of the HighLife TSMVR system in patients with [&#8230;] The post HighLife to initiate US pivotal study of transseptal mitral valve replacement system appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/highlife-us-pivotal-study/
